| Pharmaceutical active ingredients: |
| Caramiphen EdisilatePhenylpropanolamine Hydrochloride |
| Available forms, composition and doses of Tussogest Extended-Release: |
| N / A |
| Tussogest Extended-Release medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| The Harvard Drug Group |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tussocal | Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride | Perrigo |
| Tussodan DM | Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride | Odan Laboratories |
| Tusso-DF | Guaifenesin; Hydrocodone Tartrate | Everett Laboratories |
| Tussodina | Sodium Benzoate; Sodium Dibunate; Sulfogaiacol | Farmoterapica Dovalle Industria Quimica Farmaceutica |
| Tusso-DM | Dextromethorphan Hydrobromide; Iodinated Glycerol | Everett Laboratories |
| Tussoglobin | Pertussis Immune Globulin | Sanofi-Aventis |
| Tussokon | Pholcodine | Unidentified Pharmaceutical Company |
| Tussol | Liquorice; Myrtillus; Thyme; Tilia | Amnol Chimica Biologica |
| Tussol | Guaifenesin; Ipecacuanha; Oxomemazine Hydrochloride; Potassium Iodide; Sodium Benzoate | Instituto Brasileiro de Especialid Farmac |
| Tussol | Ammonium Chloride; Ammonium Glycyrrhizinate; Guaifenesin; Liquorice | Nycomed |